Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Flortaucipir F 18 | F-18-AV-1451; 18F-AV-1451; T807 | Approved | Siemens Medical Solution | Tauvid | United States | Alzheimer Disease | Avid Radiopharmaceuticals Inc | 2020-05-28 | Supranuclear Palsy, Progressive; Brain Injuries; Brain Injuries, Traumatic; Depression; Brain Concussion; Aphasia, Primary Progressive; Chronic Traumatic Encephalopathy; Pick Disease of the Brain; Alzheimer Disease; Cognitive Dysfunction; Tauopathies; Dementia; Parkinson Disease; Frontotemporal Dementia; Cognition Disorders; Neurodegenerative Diseases | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
APN-1701 | [18F]AM-PBB3; 18F-AM-PBB3; APN-1701 | Phase 2 Clinical | National Institute Of Radiological Sciences, Aprinoia Therapeutics Ltd | Nerve Degeneration; Alzheimer Disease | Details |
MC-1 (Lilly) | MC-1 (Lilly) | Phase 1 Clinical | Eli Lilly And Company | Alzheimer Disease | Details |
11C-PBB3 | 11C-PBB3 | Clinical | National Institute Of Radiological Sciences | Alzheimer Disease | Details |
[18F]THK-5105 | [18F]THK-5105 | Phase 2 Clinical | Tohoku University | Alzheimer Disease | Details |
[18F]THK-5117 | [18F]THK-5117 | Phase 2 Clinical | Tohoku University | Alzheimer Disease | Details |
ASN-120290 | ASN-120290; ASN-561; ASN-90 | Phase 1 Clinical | Merck Serono | Alzheimer Disease | Details |
ReS19-T | ReS19-T | Phase 1 Clinical | Remynd | Alzheimer Disease | Details |
TRx-0037 | TRx-0037 | Taurx Pharmaceuticals | Details | ||
Alzheimer's disease vaccine (Axon Neuroscience) | AADvac-1 | Axon Biochemicals | Details | ||
BMS-241027 | BMS-241027 | Bristol-Myers Squibb Company | Details | ||
Leuco methylthioninium | L-MTx; LMT-X; TRX-0237; Leuco-MTx; LMTM | Phase 1 Clinical | Taurx Pharmaceuticals | Cognitive Dysfunction; Alzheimer Disease | Details |
E-2814 | E-2814 | Eisai Co Ltd | Details | ||
Zagotenemab | LY-3303560 | Eli Lilly And Company | Details | ||
APNmAb-005 | APNmAb-005 | Phase 1 Clinical | Aprinoia Therapeutics Ltd | Nerve Degeneration; Alzheimer Disease; Tauopathies | Details |
[18F]GTP-1 | [18F]GTP-1 | Phase 2 Clinical | Genentech Inc | Alzheimer Disease | Details |
Lu-AF87908 | Lu-AF87908; Lu-AF-87908 | Phase 1 Clinical | H. Lundbeck A/S | Alzheimer Disease | Details |
Buntanetap | ANVS-405; ANVS-401 | Phase 3 Clinical | Raptor Pharmaceutical | Down Syndrome; Chronic Traumatic Encephalopathy; Alzheimer Disease; Cognitive Dysfunction; Parkinson Disease; Frontotemporal Dementia | Details |
BEY-2153 | BEY-2153 | Phase 1 Clinical | Beyondbio Inc | Alzheimer Disease | Details |
PNT-001 | PNT-001 | Phase 1 Clinical | Pinteon Therapeutics Inc | Brain Injuries, Traumatic; Alzheimer Disease | Details |
Protollin | Phase 1 Clinical | Brigham and Women's Hospital Inc | Alzheimer Disease | Details | |
ACI-35.030 | ACI-35.030; ACI-35 | Phase 2 Clinical | Ac Immune Sa | Brain Diseases; Cognitive Dysfunction; Alzheimer Disease; Tauopathies; Dementia; Central Nervous System Diseases | Details |
NIO-752 | NIO-752 | Phase 1 Clinical | Novartis Pharma Ag | Supranuclear Palsy, Progressive; Alzheimer Disease; Cognitive Dysfunction; Neurodegenerative Diseases | Details |
Mecripyrine Hydrochloride | SCR-1693; Y-1A | Phase 1 Clinical | Jiangsu Simcere Pharmaceutical Co Ltd, Yantai Yene Pharma Co Ltd, Nanjing Ningdan New Drug Technology Co Ltd | Alzheimer Disease | Details |
ISIS-814907 | BIIB-080; ISIS-814907; IONIS-MAPTRx; ISIS-BIIB4Rx; IONIS-BIIB4RX | Phase 2 Clinical | Biogen Inc, Ionis Pharmaceuticals Inc | Alzheimer Disease; Cognitive Dysfunction | Details |
Izaflortaucipir F-18 | [18F]PI-2620; PI-2620; 18F-PI-2620 | Phase 3 Clinical | Piramal, Ac Immune Sa | Hypotension; Supranuclear Palsy, Progressive; Brain Concussion; Frontotemporal Lobar Degeneration; Alzheimer Disease; Cognitive Dysfunction | Details |
MK-2214 | MK-2214 | Phase 1 Clinical | Merck Sharp & Dohme LLC | Alzheimer Disease | Details |
Tilavonemab | C2N-8E12; ABBV-8E12 | Phase 2 Clinical | C2n Diagnostics Llc | Supranuclear Palsy, Progressive; Alzheimer Disease | Details |
Bepranemab | UCB-0107 | Phase 2 Clinical | Ucb | Supranuclear Palsy, Progressive; Alzheimer Disease | Details |
PRX-005 | PRX-005 | Phase 1 Clinical | Prothena | Alzheimer Disease; Frontotemporal Dementia; Amyotrophic Lateral Sclerosis; Neurodegenerative Diseases | Details |
Posdinemab | JNJ-63733657; JNJ-3657 | Phase 2 Clinical | Janssen Global Services Llc | Cognitive Dysfunction; Alzheimer Disease; Dementia | Details |
APN-1607 | [18F]MNI-958; APN-0000455; F0-PBB3; PM-PBB3; APN-1607; 18F-PM-PBB3; [18F]PM-PBB3; 18F-APN-1607; [18F]APN-1607 | Phase 3 Clinical | Aprinoia Therapeutics Ltd | Supranuclear Palsy, Progressive; Nerve Degeneration; Alzheimer Disease; Cognitive Dysfunction; Diagnostic agents; Cognition Disorders | Details |
This web search service is supported by Google Inc.